Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 2,810.00
+55.00 (2.00%)
At close: Nov 13, 2026
Protia Market Cap
Protia has a market cap or net worth of 54.29 billion as of November 13, 2026. It is the 31,579th most valuable company in the world and the 1,718th biggest in South Korea. Its market cap has decreased by 16.85% in one year.
Market Cap
54.29B
Enterprise Value
40.58B
Revenue
17.75B
Global Rank
Country Rank
#1,718 South Korea
PE Ratio
6.60
ChartMarket Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 54.29B, a decrease of -30.76%. That is a compound annual growth rate of -4.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 54.29B | -32.44% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 207.48B |
| Dx & Vx | 201.29B |
| GC Medical Science | 70.21B |
| Inventera | 61.59B |
| GENINUS | 61.53B |
| Cytogen | 53.65B |
| HLB Panagene | 48.17B |
| Seoulin Bioscience | 29.45B |